Insurance Guide · Last verified June 13, 2026

Cigna Wegovy Prior Authorization: 2026 Approval Rules, Denial Fixes, and What to Do Next

By The RX Index Editorial Team · Last verified: June 13, 2026 · Built from Cigna’s own policy documents (CNF_684, CNF_915, CNF_908), FDA-approved prescribing information, and current pricing checks.

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. Some links on this page are affiliate links — we may earn a commission if you use them. That never changes what we report. This guide is general information, not medical or coverage advice. Your clinician and your Cigna plan documents control your actual care and coverage.

Here’s the short version. Cigna Wegovy prior authorization usually comes down to two gates: your plan has to cover Wegovy at all, and your doctor has to prove you meet Cigna’s rules. When Wegovy is covered under a Cigna prescription plan, prior authorization is typically required first — “prior authorization” (PA) just means your doctor has to get the plan’s approval before the pharmacy can fill it. If your plan flat-out excludes weight-loss medication, prior authorization can’t help (we cover what to do instead later).

We’re going to show you exactly how to check your plan, the precise rules, what your doctor needs to send, what every denial reason means, how to appeal, and your real options at each fork in the road. No fluff.

Does Cigna cover Wegovy, and is prior authorization always required?

Cigna covers Wegovy on some plans, but coverage depends entirely on your specific plan — and when Wegovy is covered under the pharmacy benefit, prior authorization is typically required first. Cigna’s published policy recommends prior authorization for Wegovy, but Cigna also states plainly that your individual benefit plan can override the general policy — so some employer plans exclude weight-loss drugs completely, even when Cigna’s medical policy would otherwise allow them.

Think of it as two separate gates:

1. The coverage gate. Does your plan include weight-loss medication as a benefit at all? Your employer or plan sets this — not your doctor. If the answer is no, prior authorization can’t help (we cover what to do instead later).
2. The medical gate. If your plan does cover it, do you meet Cigna’s clinical rules? That’s what prior authorization checks.

Three ways to check your coverage:

• Log in to myCigna. Use the “Price a Medication” tool or your plan’s drug list and search “Wegovy.” It usually shows whether the drug is covered, needs PA, is non-preferred, or is excluded.
• Call the number on your card. Ask: “Is Wegovy covered under my plan, and does it require prior authorization?” Then ask whether your pharmacy benefit runs through Cigna or Express Scripts.
• Use a free coverage checker if you’d rather skip the hold music.

One thing that trips people up: many Cigna pharmacy issues run through Express Scripts (Cigna’s pharmacy benefit company). So if your denial letter or insurance card names Express Scripts, that’s where your appeal goes — not a generic Cigna address.

See also: Does Cigna Cover Wegovy? →

Wait — did Cigna stop covering Wegovy in 2026?

Cigna stopped covering GLP-1 weight-loss drugs like Wegovy and Zepbound for its own employees starting July 1, 2026 — but a Cigna spokesperson confirmed the change does not affect other plans or coverage for type 2 diabetes. The key detail: the cut applies to the Cigna Group Medical Plan, the insurance Cigna gives the roughly 67,700 people who work for Cigna. It is not a blanket cancellation for everyone who has Cigna insurance.

Per Reuters (June 2, 2026) and confirmed by Cigna: Cigna emailed its employees on June 1, 2026, saying it would end its plan’s coverage of GLP-1s for weight loss as of July 1. Affected employees could refill through June 30. Cigna suggested those staff pay cash through manufacturer websites or TrumpRx, and for employees already approved, it said it would cover older weight-loss pills like phentermine instead.

So does this touch you? Almost certainly not — unless you personally work for The Cigna Group. But treat it as a warning flare: employers everywhere are tightening or dropping GLP-1 weight-loss coverage to control costs. That’s exactly why your single most important task is to confirm what your plan says right now, not assume last year’s coverage still holds.

• Don’t trust a headline. Check myCigna or call to confirm your own plan.
• If your plan is changing, get the exact effective date in writing so you can refill in time.
• If you have Cigna through work, ask HR whether weight-loss drug coverage changes at your next plan year.

What are Cigna’s Wegovy prior authorization requirements in 2026?

Under Cigna’s standard weight-management policy, an adult generally qualifies for Wegovy if they are 18 or older, have a documented 3-month trial of behavioral changes and dieting, and have either a BMI of 30 or higher OR a BMI of 27 or higher with at least one weight-related health condition. Cigna also requires that Wegovy be used alongside a reduced-calorie diet and more activity. These come straight from Cigna’s National Formulary coverage policy for GLP-1 weight-loss drugs (CNF_684).

To approve first-time Wegovy treatment, Cigna’s standard policy says you must meet all of the following:

• You’re 18 or older. (There’s a separate path for ages 12–17.)
• You’ve tried behavioral changes and dieting for at least 3 months. This is the rule that catches the most people off guard — it gets its own section below.
• Your weight meets one of these two bars:
  • A baseline BMI of 30 or higher, or
  • A baseline BMI of 27 or higher plus at least one weight-related condition (full list below).
• Wegovy will be used with diet and lifestyle changes, not on its own.

“Baseline,” in Cigna’s wording, means your measurements before you ever started any GLP-1 medication. So if a previous drug already lowered your BMI, the number that counts is where you started — which actually helps people who’ve already lost some weight.

The full list of weight-related conditions Cigna accepts

Most articles tell you “BMI 27 plus diabetes or high blood pressure.” But Cigna’s policy actually lists eleven qualifying conditions. If your BMI is between 27 and 30, check this whole list with your doctor before assuming you don’t qualify:

Cigna’s Wegovy approval rules at a glance

Source: Cigna National Formulary coverage policies CNF_684 and CNF_915, reviewed/revised through 2026. Your plan document always controls if there’s a conflict.

Cigna has more than one Wegovy rule — which one applies to you?

Cigna doesn’t have a single Wegovy rule; it has several, and which one your plan uses can change your answer. Your path depends on your plan design, whether your plan normally excludes weight-loss drugs, the reason you’re taking Wegovy, your BMI, your conditions, and whether you’re starting fresh or renewing.

1. The standard weight-management path

The everyday path most people fall under: age 18+, the 3-month diet-and-behavior trial, and BMI 30+ (or 27+ with one listed condition). It’s also generally the most achievable set of rules.

2. The “benefit-exclusion-override” path (stricter)

Some employer plans say up front that they don’t cover weight-loss drugs — but leave a door open through what Cigna calls a benefit-exclusion override. Cigna keeps a separate, dedicated override policy for these, and the bar is higher than the standard path. Under Cigna’s current GLP-1 benefit-exclusion-override policy (CNF_915), first-time Wegovy approval generally requires age 18+ and either a baseline BMI of 35 or higher, or a BMI of 27 or higher with at least two listed conditions — with a first approval of about 7 months. Some plans use a related “BMI 32” override (CNF_908) that sets the bar at a BMI of 32 or higher (or 27+ with two conditions).

3. The cardiovascular (heart) path

This one is underused. Wegovy is FDA-approved not just for weight loss but to reduce the risk of major heart events (heart attack, stroke, and cardiovascular death) in adults who have established heart disease and either obesity or overweight. Cigna’s policy mirrors that. “Established heart disease” here means a prior heart attack, a prior stroke (not a TIA), or symptomatic peripheral artery disease. If you have a heart history, raise it with your prescriber.

4. The liver disease (MASH) path

Wegovy’s injection is also FDA-approved to treat a serious liver condition called MASH (metabolic dysfunction-associated steatohepatitis, once called NASH) with moderate-to-advanced scarring. Cigna covers this, but it’s documentation-heavy: it generally requires evidence tied to stage F2–F3 liver fibrosis and that Wegovy be prescribed by — or in consultation with — an endocrinologist, gastroenterologist, or hepatologist.

5. The pediatric path (ages 12–17)

Wegovy’s injection is approved for adolescents 12 and up with obesity (a BMI at or above the 95th percentile for their age and sex). Pediatric approvals lean heavily on documentation, so let the prescriber drive this one.

One rule that blocks everyone: no doubling up

Cigna’s policy is explicit that GLP-1 medications shouldn’t be combined. If you’re already on Ozempic, Mounjaro, Zepbound, Rybelsus, Trulicity, or Victoza, you can’t also be approved for Wegovy at the same time. If a denial mentions “concurrent GLP-1 use,” that’s usually a fixable mix-up about what you’re currently taking — have your prescriber clarify your active medication list.

What does your doctor need to submit for a Cigna Wegovy prior authorization?

A strong Cigna Wegovy prior authorization makes the reviewer’s job easy: it spells out the exact medication, the reason for it, your baseline BMI, your qualifying conditions, your documented 3-month lifestyle effort, and confirmation you’re not on another GLP-1. Cigna warns that missing information is a common reason requests get denied — so the safest submission is specific, dated, and tied directly to Cigna’s rules.

Your prescriber’s office submits the request electronically, usually through a system like CoverMyMeds or Surescripts. You don’t submit your own medical records — but you can make sure your doctor has everything they need before they hit send. Here’s the checklist to bring.

How do you prove Cigna’s 3-month diet and behavior requirement?

Cigna’s standard adult Wegovy rules require at least 3 months of documented behavioral changes and dieting before a first approval — but this does not mean you need a fancy paid diet program; it means your doctor should be able to show a dated, reasonable weight-management effort. This single requirement causes more confusion and more avoidable denials than any other part of the process.

The good news: the bar is more flexible than people fear. What Cigna wants is evidence you’ve genuinely tried to manage your weight through lifestyle, with dates attached. Talk to your prescriber about which of these fit you:

• Clinic notes showing your doctor counseled you on diet and behavior
• Weight logs with dates
• Notes from a dietitian or nutritionist
• Records from a medically supervised or employer wellness weight program
• Food and activity logs from an app, if your prescriber will document them
• Exercise program notes
• Earlier diet or medication attempts already in your chart
• Follow-up visits that show ongoing effort

The trick is the paper trail. A casual “I’ve been trying to eat better” isn’t documentation. A chart note dated three-plus months ago that says you discussed a reduced-calorie diet and have been tracking it — that’s documentation. Ask your prescriber to add the relevant history to your chart before they submit, not after.

Before you start Wegovy: who should talk to a prescriber first?

Getting your insurance to approve Wegovy is not the same as being medically cleared to take it. According to Wegovy’s FDA-approved prescribing information, Wegovy carries a boxed warning about possible thyroid tumors, including cancer, seen in animal studies. This is a brief summary, not the full safety information — read the Medication Guide and talk to your doctor.

Reported side effects range from common stomach issues (nausea, vomiting, diarrhea, constipation) to more serious risks like pancreatitis, gallbladder problems, kidney problems, and allergic reactions. For full details, see the Wegovy Prescribing Information and Medication Guide.

How long does a Cigna Wegovy approval last, and when should you renew?

Cigna’s standard adult weight-loss policy generally approves Wegovy for about 8 months on the first authorization, then for up to 1 year on renewal if you’ve responded to treatment — typically meaning at least 5% weight loss from your starting weight. Some pathways, like the heart or liver pathways, run up to 1 year.

For renewals, Cigna leans on a well-established benchmark: response to a weight-loss medication is judged at around 3 months on a full dose, and at least 5% weight loss from baseline signals the drug is worth continuing. When it’s time to renew, your prescriber should document your starting weight, your current weight, the percentage you’ve lost, and that you’re still doing the lifestyle work.

Why does Cigna deny Wegovy prior authorization?

A Cigna Wegovy denial almost always falls into one of two buckets: either your plan doesn’t cover Wegovy for that purpose, or your submission didn’t prove the plan’s rules — and the fix is completely different depending on which. Your denial letter names the reason, and that reason is your roadmap.

Save these details from your denial letter: the exact reason, the case or reference number, the criteria Cigna cited, the appeal deadline, the fax or upload instructions, and any pharmacy rejection code. You’ll need them. Don’t appeal blindly — match your appeal to the actual denial reason, every time.

How do you appeal a Cigna Wegovy denial?

If Cigna denies Wegovy, you generally have 180 days from the date on your denial letter to file an internal appeal. If the denial relates to Express Scripts pharmacy coverage, follow the Express Scripts appeal instructions; otherwise, use the appeal route shown on your Cigna denial letter or card.

Here’s the order to work through:

1. Get the reason in writing. Call the number on your denial letter and pin down: Was Wegovy covered but the PA denied, or is Wegovy excluded? Which policy did they use? Which exact requirement wasn’t met? What’s the appeal deadline? Write it all down.
2. Match the denial to the right pathway. Is your plan applying the standard rule, an override, the heart path, or the liver path? That shapes your whole appeal.
3. Ask your prescriber whether to resubmit or appeal. For a missing-documentation or “criteria not met” denial, your doctor often just needs to send more proof.
4. Know the clock. Here’s the appeal timeline most commercial plans follow:

Step 5 — Write a Letter of Medical Necessity that answers the exact denial. The strongest letters, written by your prescriber, name the denial reason head-on and answer it with specifics: your baseline BMI, your qualifying conditions, your documented lifestyle effort, and the clinical reasoning for Wegovy.

Appeals work when they answer the real denial reason with fresh, specific documentation. They fail when they argue the wrong issue.

What if Cigna says Wegovy isn’t covered at all?

If Cigna says Wegovy is excluded — meaning your plan simply doesn’t pay for weight-loss drugs — a stronger prior authorization usually can’t fix it, because an exclusion is a plan-design decision, not a medical one. Your next steps are to confirm the exclusion in your plan document, ask whether any exception or non-weight-loss pathway applies, and then compare your cash-pay and telehealth options if coverage truly isn’t available.

First, make sure “not covered” really means excluded. These sound similar but aren’t:

• PA denied = coverage may exist, but you didn’t prove (or meet) the rules. Often fixable.
• Excluded / not covered = the plan won’t pay even with a perfect PA. Usually not fixable through appeal.
• Non-formulary = not on the preferred list; may need an exception or a different drug.
• Wrong formulation = the pen, tablet, and HD versions can be treated differently by your plan.

Ask Cigna these exact questions before you decide:

1. Is Wegovy excluded, or just PA-required?
2. Does the exclusion apply to all Wegovy formulations?
3. Does my plan cover Wegovy for cardiovascular risk reduction?
4. Is there a benefit-exclusion-override process I can use?
5. Is another FDA-approved weight or obesity medication covered instead?
6. Is my pharmacy benefit run by Cigna or Express Scripts?
7. What exact documentation would change the decision?

How much does Wegovy cost with and without Cigna coverage?

With Cigna coverage and the manufacturer savings card, people on commercial (non-government) plans can pay as little as $25 a month for Wegovy; without coverage, self-pay through NovoCare starts at $199 a month for the first two months on the pen (then $349) or $149 a month for the pill, versus a list price near $1,349. What you actually pay depends entirely on which branch of the decision tree you land on.

Prices verified from NovoCare and Wegovy.com; confirm current pricing before you commit, since several offers carry expiration dates.

Can Ro help with your Cigna Wegovy prior authorization?

Ro can be a strong next step because it offers a free GLP-1 Insurance Coverage Checker and, for members, an insurance concierge that verifies benefits and submits prior authorization paperwork — but Ro can’t guarantee Cigna approval, and it generally can’t get government plans to cover your medication.

Is Wegovy covered under Cigna Medicare, Medicaid, or marketplace plans?

Most Cigna Wegovy prior authorization questions come from commercial and employer plans — but Medicare, Medicaid, and marketplace plans follow their own rules, so check your exact plan type before applying the standard checklist. The manufacturer’s $25 commercial savings card does not work on government plans, though a separate Medicare path is rolling out.

• Commercial / employer plans. The main audience for this guide. Your employer chooses whether weight-loss drugs are covered, and your plan document is the final word. The standard PA rules above generally apply when coverage exists.
• Medicare. Federal rules have long limited coverage of drugs used purely for weight loss, though FDA-approved non-weight-loss uses (like heart-risk reduction) can be treated differently. New for 2026: Novo says that starting July 1, 2026, eligible Medicare patients prescribed Wegovy for a covered FDA-approved indication can get all pen and pill doses for $50/month — eligibility set by CMS, not a guarantee of coverage. Check your specific Part D plan.
• Medicaid. Coverage is set state by state and changes often. Contact your state’s Medicaid program or your plan’s member services.
• Marketplace (ACA) plans. Formularies and PA rules vary by plan. Same first step: check your exact plan’s drug list.

If you have a government plan, don’t rely on the commercial savings-card path. Check your exact Medicare, Medicaid, TRICARE, or marketplace rules — and look into the Medicare $50 path above if you may be eligible.

Cigna Wegovy prior authorization FAQ

How we verified this guide

We built this guide by reading Cigna’s own Wegovy-related policy documents, FDA-approved prescribing information, and current manufacturer and provider pricing pages — not by paraphrasing other blogs.

Sources we checked

• Cigna National Formulary Coverage Policy — Weight Loss GLP-1 Agonists Prior Authorization (CNF_684), revised through 2026
• Cigna National Formulary Coverage Policy — Weight Loss GLP-1 Agonists Benefit Exclusion Overrides (CNF_915), and the EncircleRx BMI 32 policy (CNF_908)
• Cigna Healthcare — Appeals and Disputes (provider and member appeal routing)
• FDA-approved Wegovy (semaglutide) Prescribing Information and Medication Guide, Novo Nordisk
• Reuters — “Cigna drops coverage of GLP-1 obesity drugs for its own employees,” June 2, 2026
• Wegovy.com and NovoCare — Wegovy cost, savings, self-pay pricing, and the Medicare access program (verify current details and dates)
• HealthCare.gov — Internal appeals and External review (timelines and rights)
• ro.co — GLP-1 Insurance Coverage Checker, insurance concierge, pricing, and government-plan eligibility (verify current details)

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This guide is educational and is not medical or insurance advice.